Chrysalis Intelligence · Product Codes · QOF

QOF · Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents

Microbiology · 33 clearances · 17 unique sponsors

Device class
Class II
Regulation 866.3981
Total clearances
33
2021-03-17 → 2026-06-12
Last 12 months
5
Unique sponsors
17
Definition

What is Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents

A device to detect and identify nucleic acid targets in respiratory specimens from microbial agents that cause the SARS-CoV-2 respiratory infection and other microbial agents when in a multi-target test is an in vitro diagnostic device intended for the detection and identification of SARS-CoV-2 and other microbial agents when in a multi-target test in human clinical respiratory specimens from patients suspected of respiratory infection who are at risk for exposure or who may have been exposed to these agents. The device is intended to aid in the diagnosis of respiratory infection in conjunction with other clinical, epidemiologic, and laboratory data or other risk factors.
Medical specialty
Microbiology
Review panel
MI
Regulation number
866.3981
Implant
N
Life-sustain / support
N
GMP exempt
N
Third-party review
N
Trend

Clearance volume by quarter

Players

Top sponsors in this product code

Sponsor Clearances Last 12 mo Most recent
Biofire Diagnostics 6 0 2025-08-14
Roche Molecular Systems, Inc. 4 0 2025-07-31
Hologic, Inc. 3 0 2024-11-15
Diasorin Molecular, LLC 3 2 2025-12-23
QIAGEN GmbH 3 0 2025-08-27
Cepheid® 3 0 2025-05-01
Bd Integrated Diagnostic Solutions / 1 0 2023-07-31
Cepheid 1 0 2025-01-10
Luminex Corporation 1 0 2024-03-01
Visby Medical, Inc. 1 0 2025-02-19
Lex Diagnostics Limited 1 1 2026-02-13
Autonomous Medical Devices Incorporated 1 1 2026-06-12
Abbott Molecular, Inc. 1 0 2025-02-14
Luminex Molecular Diagnostics, Inc. 1 0 2024-03-11
Life Technologies Corporation 1 0 2025-01-08
Baebies, Inc. 1 1 2026-03-30
Nuclein, LLC 1 0 2024-12-20
Reimbursement

Likely billing codes (AI-inferred · verify with billing)

Healthcare providers using this device would typically bill under these HCPCS Level II (alphanumeric) or CPT (5-digit) codes. Mapping inferred from device function by Claude Haiku; official descriptions pulled from the CMS HCPCS April 2026 quarterly file where available. Always verify with billing/coding teams before relying on these.

CodeTypeDescriptionConfidenceRationale
87635 CPT High Infectious agent antigen detection by immunoassay technique, analyte varies; standard respiratory viral multiplex panel code
87811 CPT Medium Infectious agent detection by nucleic acid; applicable for multiplex nucleic acid respiratory tests
U0001 CPT Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel ✓ CMS-verified description Medium 2019-nCoV Coronavirus SARS-CoV-2 nucleic acid-based panel; specific code for SARS-CoV-2 multi-target testing
Pulse

Most recent 510(k) clearances

DateK-numberSponsorDevice
2026-06-12 K252932 Autonomous Medical Devices Incorporated Fast PCR Mini Respiratory Panel
2026-03-30 K252269 Baebies, Inc. FINDER Flu A&B/SARS-CoV-2 Test
2026-02-13 K251742 Lex Diagnostics Limited VELO Respiratory Test
2025-12-23 K251978 Diasorin Molecular, LLC LIAISON NES FLU A/B, RSV & COVID-19
2025-10-30 K252387 Diasorin Molecular, LLC Simplexa™ COVID-19/ Flu A/B & RSV Direct (MOL4450); Simplexa™ COVID-19/ Flu A/B & RSV Positive Control Pack (MOL4460)
2025-08-27 K250080 QIAGEN GmbH QIAstat-Dx Respiratory Panel Plus; QIAstat-Dx Respiratory Panel Mini
2025-08-14 K243544 Biofire Diagnostics, LLC BIOFIRE SPOTFIRE Respiratory/Sore Throat Panel Mini
2025-07-31 K243455 Roche Molecular Systems, Inc. cobas Respiratory 4-flex for use on the cobas 5800/6800/8800 Systems
2025-05-01 K250996 Cepheid® Xpert Xpress CoV-2/Flu/RSV plus
2025-05-01 K250995 Cepheid® Xpert Xpress CoV-2/Flu/RSV plus
2025-04-25 K243406 Roche Molecular Systems, Inc. cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test
2025-04-25 K243400 Roche Molecular Systems, Inc. cobas liat SARS-CoV-2 & Influenza A/B v2 nucleic acid test
2025-02-19 K242526 Visby Medical, Inc. Visby Medical Respiratory Health Test
2025-02-14 K241573 Abbott Molecular, Inc. Alinity m Resp-4-Plex
2025-01-10 K242071 Cepheid Xpert Xpress CoV-2/Flu/RSV plus
2025-01-08 K241806 Life Technologies Corporation Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel
2024-12-20 K241652 Nuclein, LLC DASH® SARS-CoV-2 & Flu A/B Test
2024-11-15 K242465 Hologic, Inc. Panther Fusion SARS-CoV-2/Flu A/B/RSV assay
2024-10-25 K242353 QIAGEN GmbH QIAstat-Dx Respiratory Panel Mini
2024-07-18 K241240 Hologic, Inc. Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay
2024-05-30 K241194 Biofire Diagnostics, LLC BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel Mini
2024-05-10 K233100 QIAGEN GmbH QIAstat-Dx® Respiratory Panel Plus
2024-03-26 K232954 Biofire Diagnostics, LLC BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel
2024-03-11 K231758 Luminex Molecular Diagnostics, Inc. NxTAG Respiratory Pathogen Panel v2 (NxTAG RPP v2)
2024-03-01 K233410 Luminex Corporation LIAISON PLEX Respiratory Flex Assay